Episode

Retatrutide Alert: Six Cases of Liver Damage

Podcast
Australia News Today | 2 Min News | The Daily News Now!
Published
Jun 19, 2026
Duration seconds
97
Processing state
not_requested
Canonical source
https://api.fastcast.ai/audio/055e197f-840c-4fb6-9237-44c802b73ae7.mp3
Audio
https://api.fastcast.ai/audio/055e197f-840c-4fb6-9237-44c802b73ae7.mp3
JSON
/v1/public/podcasts/australia-news-today-2-min-news-the-daily-news-now-7569932/episodes/retatrutide-alert-six-cases-of-liver-damage
Markdown
/podcast/australia-news-today-2-min-news-the-daily-news-now-7569932/retatrutide-alert-six-cases-of-liver-damage.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/australia-news-today-2-min-news-the-daily-news-now-7569932/episodes/retatrutide-alert-six-cases-of-liver-damage/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/australia-news-today-2-min-news-the-daily-news-now-7569932/retatrutide-alert-six-cases-of-liver-damage.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Health officials are warning the public about a dangerous, unapproved peptide called Retatrutide, linked to severe liver damage in six Victorians since January. Not available in pharmacies, it’s been sold online under names like Reta or R-10. The TGA says it hasn’t been tested for safety or efficacy, and contamination risks are high. Symptoms include extreme fatigue, jaundice, stomach pain, dark urine, or bruising — if you’ve used it and notice any, seek medical help immediately. Authorities urge anyone with the product to dispose of it safely and report symptoms right away. Support the show: Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN: [email protected] This is an automated, high-level news summary based on public reporting. Report issues to [email protected]. View sources & latest updates: https://sources.thednn.ai/9ec0133479ba93ef